Skip to main content

Conference Highlights ADA

Conference Highlights ADA

Once-Weekly GLP-1 Agonist Noninferior to Metformin in Treatment-Naïve Patients with Type 2 Diabetes

Conference Highlights ADA

Adding Saxagliptin to Metformin Improves Glycemic Control Over Uptitrating Metformin Dose

Conference Highlights ADA

Initiation of Therapy with a Sulfonylurea Increased Risk of Cardiovascular Events versus Metformin in Older Adults with Type 2 Diabetes

Conference Highlights ADA

Linagliptin as Effective as Glimepiride with Improved Safety Profile

Conference Highlights ADA

Diabetes Prevention with Metformin Is Cost-Saving for Persons at High Risk

Conference Highlights ADA

Nurse Educators as Part of Team Approach Improve Outcomes and Lower Costs Associated with Diabetes

Conference Highlights ADA

Blood Glucose Testing a Significant Contributor to Pharmacy Costs in Patients Using Insulin

Perspectives, Conference Highlights ADA

ADA President’s Views on Clinical Management of Type 2 Diabetes

Conference Highlights ADA

Insulin Inappropriately Discontinued in Many Type 2 Diabetes Patients After Hospitalization

Conference Highlights ADA

Type 2 Diabetes Treatment in Patients with CKD Should Conform to NKF Guidelines for Better Outcomes, Lower Costs

Page 2 of 3
Results 11 - 20 of 22